Healthcare >> Analyst Interviews >> July 25, 2005

LIFE SCIENCE TOOLS & INSTRUMENTS: TED TENTHOFF – PIPER JAFFRAY & CO

TWST: Ted, let's talk about your biotech coverage. How do you

characterize it?

Mr. Tenthoff: I would characterize my coverage as drug discovery, which

is really bifurcated into two spaces; the